Transfected Stable Cell Lines

Xpress™ Human CD39 Over-expressing Cell Line (CT26)

  • For research use only

Cat No.

ABC-X0137C

Product Type

Overexpression Stable Cell Lines

Cell Type

Epithelial-like

Species

Human

Host Cell

CT26

Source Organ

Colon

Disease

Colorectal Carcinoma

Storage

Liquid Nitrogen

The Xpress™ Human CD39 Overexpressing Cell Line (CT26) is an important model for researching immune tolerance and tumor microenvironment interactions.

Product Image

Description

Xpress™ Human CD39 over-expressing cell line (CT26) is a genetically engineered model derived from selected murine CT26 parental cell line based on customers’ requirement. Human CD39 overexpression cell line is generated by stable integration of exogenous human CD39 gene into CT26 host cells using our optimized transduction of lentiviral vectors. Overexpression clone is validated at gene level by qRT-PCR.
Target
CD39 (ENTPD1) is an ectonucleotidase that hydrolyzes extracellular ATP and ADP into AMP, contributing to the immunosuppressive adenosine pathway. It is widely expressed in the tumor microenvironment and associated with regulatory T cell function, immune tolerance, and poor cancer prognosis. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.

Species

Human

Cat.No

ABC-X0137C

Product Category

Transfected Stable Cell Lines

Size/Quantity

1 vial

Cell Type

Epithelial-like

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 °C, 5% CO₂

Source Organ

Colon

Disease

Colorectal Carcinoma

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Overexpression Stable Cell Lines

Host Cell

CT26

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • The Xpress™ Human CD39 over-expressing cell line (CT26) is a suitable model for investigating adenosine-mediated immunosuppression and for screening CD39 inhibitors. It is widely used in the development of cancer immunotherapy and metabolic pathway modulators.

Inquiring Xpress™ Human CD39 Over-expressing Cell Line (CT26)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button